Author:
P Ketan Mallya,M Deepak Nayak,V.Belurkar Sushma,Manohar Chethan
Publisher
Akshantala Enterprises Private Limited
Reference15 articles.
1. Treatment and prognostic impact of transient leukaemia in neonates with Down's syndrome;Klusmann;Blood,2008
2. 2. Baumann I, Niemeyer CM, Brunning RD, Arber DA, Porwit A. Myeloid proliferations related to Down'ssyndrome. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. Swedlow SH et al (editors).IARC, Lyon 2008:142-144.
3. 3. Payne E,Salamt A, Connor P. Transient abnormal myelopoiesis in an infant with Down's syndrome. Libyan J Med. 2010, 5: 4635 - DOI: 10.3402/ljm.v5i0.4635.
4. 4. Dixon N. Kishnani PS, Zimmerman S. Clinical manifestations of hematologic and oncologic disorders in patients with Down's syndrome. Am J Med Genet C Semin Med Genet.2006; 142:149-157.
5. 5. Webb D, Roberts I, Vyas P. Haematology of Down's syndrome. Arch Dis Child Fetal Neonatal. Ed. 2007; 92:503-507.